A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia

✍ Scribed by Kirschbaum, M H; Synold, T; Stein, A S; Tuscano, J; Zain, J M; Popplewell, L; Karanes, C; O'Donnell, M R; Pulone, B; Rincon, A

• Book ID: 109887446
• Publisher: Nature Publishing Group
• Year: 2011
• Tongue: English
• Weight: 213 KB
• Volume: 25
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/leu.2011.124